Existing research has proven increased levels of TNFRII in tumour cell lines and tumour tissues, which predicts a later clinical stage and worse prognosis,25, 26 but far too little attention has been paid to the role of TNFRII in risk prediction for early‐stage lung adenocarcinoma. This evidence concerns the gene TNFRSF1B and lung adenocarcinoma.